{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:15:45Z","timestamp":1793751345524,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770463 and 82070469"],"award-info":[{"award-number":["81770463 and 82070469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Cordyceps militaris<\/jats:italic> is cultured widely as an edible mushroom and accumulating evidence in mice have demonstrated that the polysaccharides of <jats:italic>Cordyceps<\/jats:italic> species have lipid-lowering effects. However, lipid metabolism in mice is significantly different from that in humans, making a full understanding of the mechanisms at play critical.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After 5 months, the hamsters were weighed and sampled under anesthesia after overnight fasting. The lipid-lowering effect and mechanisms of the polysaccharide CM1 was investigated by cellular and molecular technologies. Furthermore, the effect of the polysaccharide CM1 (100\u2009\u03bcg\/mL) on inhibiting adipocyte differentiation was investigated in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CM1, a polysaccharide from <jats:italic>C. militaris<\/jats:italic>, significantly decreased plasma total cholesterol, triglyceride and epididymal fat index in LDLR<jats:sup><jats:italic>(+\/\u2212)<\/jats:italic><\/jats:sup> hamsters, which have a human-like lipid profile. After 5\u2009months\u2019 administration, CM1 decreased the plasma level of apolipoprotein B48, modulated the expression of key genes and proteins in liver, small intestine, and epididymal fat. CM1 also inhibited preadipocyte differentiation in 3T3-L1 cells by downregulating the key genes involved in lipid droplet formation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The polysaccharide CM1 lowers lipid and adipocyte differentiation by several pathways, and it has potential applications for hyperlipidemia prevention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01606-6","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T03:02:23Z","timestamp":1639364543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Polysaccharide CM1 from Cordyceps militaris hinders adipocyte differentiation and alleviates hyperlipidemia in LDLR(+\/\u2212) hamsters"],"prefix":"10.1186","volume":"20","author":[{"given":"Wen-Qian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7945-6139","authenticated-orcid":false,"given":"Shou-Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"issue":"4","key":"1606_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203\u201312. https:\/\/doi.org\/10.1038\/s41569-018-0119-4.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"1606_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","volume":"121","author":"DP Leong","year":"2017","unstructured":"Leong DP, Joseph PG, McKee M, Anand SS, Teo KK, Schwalm JD, et al. Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease. Circ Res. 2017;121(6):695\u2013710. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311849.","journal-title":"Circ Res"},{"key":"1606_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4\u201333. https:\/\/doi.org\/10.1016\/j.addr.2020.07.019.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1606_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12944-020-1202-5","volume":"19","author":"B Xia","year":"2020","unstructured":"Xia B, Lin P, Ji Y, Yin J, Wang J, Yang X, et al. Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters. Lipids Health Dis. 2020;19(1):24. https:\/\/doi.org\/10.1186\/s12944-020-1202-5.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1606_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.physiol.69.031905.160725","volume":"69","author":"DQ Wang","year":"2007","unstructured":"Wang DQ. Regulation of intestinal cholesterol absorption. Annu Rev Physiol. 2007;69(1):221\u201348. https:\/\/doi.org\/10.1146\/annurev.physiol.69.031905.160725.","journal-title":"Annu Rev Physiol"},{"issue":"23","key":"1606_CR6","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1073\/pnas.0500269102","volume":"102","author":"M Garcia-Calvo","year":"2005","unstructured":"Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, et al. The target of ezetimibe is Niemann-pick C1-like 1 (NPC1L1). Proc Natl Acad Sci U S A. 2005;102(23):8132\u20137. https:\/\/doi.org\/10.1073\/pnas.0500269102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1606_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0975-9476.78183","volume":"2","author":"AK Panda","year":"2011","unstructured":"Panda AK, Swain KC. Traditional uses and medicinal potential of Cordyceps sinensis of Sikkim. J Ayurveda Integr Med. 2011;2(1):9\u201313. https:\/\/doi.org\/10.4103\/0975-9476.78183.","journal-title":"J Ayurveda Integr Med"},{"key":"1606_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ijbiomac.2019.04.020","volume":"132","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wen C, Duan Y, Zhang H, Ma H. Advance in Cordyceps militaris (Linn) link polysaccharides: isolation, structure, and bioactivities: a review. Int J Biol Macromol. 2019;132:906\u201314. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.04.020.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"1606_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3109\/07388551.2014.900604","volume":"35","author":"JD Cui","year":"2015","unstructured":"Cui JD. Biotechnological production and applications of Cordyceps militaris, a valued traditional Chinese medicine. Crit Rev Biotechnol. 2015;35(4):475\u201384. https:\/\/doi.org\/10.3109\/07388551.2014.900604.","journal-title":"Crit Rev Biotechnol"},{"key":"1606_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ijbiomac.2021.04.083","volume":"181","author":"X Yang","year":"2021","unstructured":"Yang X, Lin P, Wang J, Liu N, Yin F, Shen N, et al. Purification, characterization and anti-atherosclerotic effects of the polysaccharides from the fruiting body of Cordyceps militaris. Int J Biol Macromol. 2021;181:890\u2013904. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.04.083.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1606_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1248\/bpb.26.84","volume":"26","author":"JH Koh","year":"2003","unstructured":"Koh JH, Kim JM, Chang UJ, Suh HJ. Hypocholesterolemic effect of hot-water extract from mycelia of Cordyceps sinensis. Biol Pharm Bull. 2003;26(1):84\u20137. https:\/\/doi.org\/10.1248\/bpb.26.84.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"1606_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jep.2013.10.064","volume":"151","author":"SB Kim","year":"2014","unstructured":"Kim SB, Ahn B, Kim M, Ji HJ, Shin SK, Hong IP, et al. Effect of Cordyces militaris extract and active constituents on metabolic parameters of obesity induced by high-fat diet in C58BL\/6J mice. J Ethnopharmacol. 2014;151(1):478\u201384. https:\/\/doi.org\/10.1016\/j.jep.2013.10.064.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1606_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/nu11051015","volume":"11","author":"NKS Tran","year":"2019","unstructured":"Tran NKS, Kim GT, Park SH, Lee D, Shim SM, Park TS. Fermented Cordyceps militaris extract prevents hepatosteatosis and adipocyte hypertrophy in high fat diet-fed mice. Nutrients. 2019;11(5):1015. https:\/\/doi.org\/10.3390\/nu11051015.","journal-title":"Nutrients"},{"issue":"7","key":"1606_CR14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.phytochem.2008.01.027","volume":"69","author":"RR Paterson","year":"2008","unstructured":"Paterson RR. Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry. 2008;69(7):1469\u201395. https:\/\/doi.org\/10.1016\/j.phytochem.2008.01.027.","journal-title":"Phytochemistry"},{"key":"1606_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ebiom.2017.12.013","volume":"27","author":"X Guo","year":"2018","unstructured":"Guo X, Gao M, Wang Y, Lin X, Yang L, Cong N, et al. LDL receptor gene-ablated hamsters: a rodent model of familial hypercholesterolemia with dominant inheritance and diet-induced coronary atherosclerosis. EBioMedicine. 2018;27:214\u201324. https:\/\/doi.org\/10.1016\/j.ebiom.2017.12.013.","journal-title":"EBioMedicine"},{"key":"1606_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-981-15-6082-8_9","volume":"1276","author":"S Guo","year":"2020","unstructured":"Guo S, Xia XD, Gu HM, Zhang DW. Proprotein convertase subtilisin\/Kexin-type 9 and lipid metabolism. Adv Exp Med Biol. 2020;1276:137\u201356. https:\/\/doi.org\/10.1007\/978-981-15-6082-8_9.","journal-title":"Adv Exp Med Biol"},{"key":"1606_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijbiomac.2019.03.078","volume":"131","author":"S Hu","year":"2019","unstructured":"Hu S, Wang J, Li F, Hou P, Yin J, Yang Z, et al. Structural characterisation and cholesterol efflux improving capacity of the novel polysaccharides from Cordyceps militaris. Int J Biol Macromol. 2019;131:264\u201372. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.03.078.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"1606_CR18","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1111\/jcmm.15012","volume":"24","author":"T Li","year":"2020","unstructured":"Li T, Hu SM, Pang XY, Wang JF, Yin JY, Li FH, et al. The marine-derived furanone reduces intracellular lipid accumulation in vitro by targeting LXR\u03b1 and PPAR\u03b1. J Cell Mol Med. 2020;24(6):3384\u201398. https:\/\/doi.org\/10.1111\/jcmm.15012.","journal-title":"J Cell Mol Med"},{"key":"1606_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijbiomac.2021.02.191","volume":"179","author":"J Wang","year":"2021","unstructured":"Wang J, Wang Y, Yang X, Lin P, Liu N, Li X, et al. Purification, structural characterization, and PCSK9 secretion inhibitory effect of the novel alkali-extracted polysaccharide from Cordyceps militaris. Int J Biol Macromol. 2021;179:407\u201317. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.02.191.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"1606_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/15376516.2020.1747124","volume":"30","author":"V Adomshick","year":"2020","unstructured":"Adomshick V, Pu Y, Veiga-Lopez A. Automated lipid droplet quantification system for phenotypic analysis of adipocytes using CellProfiler. Toxicol Mech Methods. 2020;30(5):378\u201387.","journal-title":"Toxicol Mech Methods"},{"issue":"17","key":"1606_CR21","first-page":"3316","volume":"39","author":"SD Guo","year":"2014","unstructured":"Guo SD, Cui YJ, Wang RZ, Wang RY, Wu WX, Ma T. Separation, purification and primary reverse cholesterol transport study of Cordyceps militaris polysaccharide. China J Chin Mater Med. 2014;39(17):3316\u201320.","journal-title":"China J Chin Mater Med"},{"issue":"8","key":"1606_CR22","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1039\/C9FO00619B","volume":"10","author":"J Yin","year":"2019","unstructured":"Yin J, Wang J, Li F, Yang Z, Yang X, Sun W, et al. The fucoidan from the brown seaweed Ascophyllum nodosum ameliorates atherosclerosis in apolipoprotein E-deficient mice. Food Funct. 2019;10(8):5124\u201339. https:\/\/doi.org\/10.1039\/C9FO00619B.","journal-title":"Food Funct"},{"issue":"1","key":"1606_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7497\/j.issn.2095-3941.2014.0019","volume":"12","author":"JY Zhang","year":"2015","unstructured":"Zhang JY, Zhang F, Hong CQ, Giuliano AE, Cui XJ, Zhou GJ, et al. Critical protein GAPDH and its regulatory mechanisms in cancer cells. Cancer Biol Med. 2015;12(1):10\u201322. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2014.0019.","journal-title":"Cancer Biol Med"},{"issue":"23","key":"1606_CR24","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.3390\/ijms20235936","volume":"20","author":"Y Wu","year":"2019","unstructured":"Wu Y, Xu MJ, Cao Z, Yang C, Wang J, Wang B, et al. Heterozygous Ldlr-deficient hamster as a model to evaluate the efficacy of PCSK9 antibody in hyperlipidemia and atherosclerosis. Int J Mol Sci. 2019;20(23):5936. https:\/\/doi.org\/10.3390\/ijms20235936.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1606_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbrc.2010.05.114","volume":"398","author":"S Gao","year":"2010","unstructured":"Gao S, He L, Ding Y, Liu G. Mechanisms underlying different responses of plasma triglyceride to high-fat diets in hamsters and mice: roles of hepatic MTP and triglyceride secretion. Biochem Biophy Res Commun. 2010;398(4):619\u201326. https:\/\/doi.org\/10.1016\/j.bbrc.2010.05.114.","journal-title":"Biochem Biophy Res Commun"},{"issue":"9","key":"1606_CR26","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/jn\/130.9.2166","volume":"130","author":"SK Reaves","year":"2000","unstructured":"Reaves SK, Wu JY, Wu Y, Fanzo JC, Wang YR, Lei PP, et al. Regulation of intestinal apolipoprotein B mRNA editing levels by a zinc-deficient diet and cDNA cloning of editing protein in hamsters. J Nutr. 2000;130(9):2166\u201373. https:\/\/doi.org\/10.1093\/jn\/130.9.2166.","journal-title":"J Nutr"},{"issue":"3","key":"1606_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.14218\/JCTH.2017.00061","volume":"6","author":"A Moslehi","year":"2018","unstructured":"Moslehi A, Hamidi-Zad Z. Role of SREBPs in liver diseases: a mini-review. J Clin Transl Hepatol. 2018;6(3):332\u20138. https:\/\/doi.org\/10.14218\/JCTH.2017.00061.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"1606_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1871529X18666180302113713","volume":"18","author":"S Guo","year":"2018","unstructured":"Guo S, Li L, Yin H. Cholesterol homeostasis and liver X receptor (LXR) in atherosclerosis. Cardiovasc Hematol Disord Drug Targets. 2018;18(1):27\u201333. https:\/\/doi.org\/10.2174\/1871529X18666180302113713.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"1606_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cca.2019.09.022","volume":"500","author":"HX Yang","year":"2020","unstructured":"Yang HX, Zhang M, Long SY, Tuo QH, Tian Y, Chen JX, et al. Cholesterol in LDL receptor recycling and degradation. Clin Chim Acta. 2020;500:81\u20136. https:\/\/doi.org\/10.1016\/j.cca.2019.09.022.","journal-title":"Clin Chim Acta"},{"key":"1606_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bcp.2019.04.008","volume":"164","author":"MX Ge","year":"2019","unstructured":"Ge MX, Shao RG, He HW. Advances in understanding the regulatory mechanism of cholesterol 7\u03b1-hydroxylase. Biochem Pharmacol. 2019;164:152\u201364. https:\/\/doi.org\/10.1016\/j.bcp.2019.04.008.","journal-title":"Biochem Pharmacol"},{"issue":"7\u20138","key":"1606_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/00498250802007930","volume":"38","author":"S Kidambi","year":"2008","unstructured":"Kidambi S, Patel SB. Cholesterol and non-cholesterol transporters: ABCG5, ABCG8 and NPC1L1: a review. Xenobiotica. 2008;38(7\u20138):1119\u201339. https:\/\/doi.org\/10.1080\/00498250802007930.","journal-title":"Xenobiotica"},{"issue":"3","key":"1606_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/MOL.0b013e3283468c28","volume":"22","author":"C Pramfalk","year":"2011","unstructured":"Pramfalk C, Jiang ZY, Parini P. Hepatic Niemann-pick C1-like 1. Curr Opin Lipidol. 2011;22(3):225\u201330. https:\/\/doi.org\/10.1097\/MOL.0b013e3283468c28.","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"1606_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5551\/jat.14.99","volume":"14","author":"HR Davis","year":"2007","unstructured":"Davis HR, Veltri EP. Zetia: inhibition of Niemann-pick C1 like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. J Atheroscler Tromb. 2007;14(3):99\u2013108. https:\/\/doi.org\/10.5551\/jat.14.99.","journal-title":"J Atheroscler Tromb"},{"issue":"6","key":"1606_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cmet.2008.04.001","volume":"7","author":"L Ge","year":"2008","unstructured":"Ge L, Wang J, Qi W, Miao HH, Cao J, Qu YX, et al. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 2008;7(6):508\u201319. https:\/\/doi.org\/10.1016\/j.cmet.2008.04.001.","journal-title":"Cell Metab"},{"issue":"6","key":"1606_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bbalip.2018.10.008","volume":"1864","author":"R Schreiber","year":"2019","unstructured":"Schreiber R, Xie H, Schweiger M. Of mice and men: the physiological role of adipose triglyceride lipase (ATGL). Biochim. Biophys. Acta Mol Cell Biol Lipids. 2019;1864(6):880\u201399. https:\/\/doi.org\/10.1016\/j.bbalip.2018.10.008.","journal-title":"Acta Mol Cell Biol Lipids"},{"issue":"4","key":"1606_CR36","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3892\/mmr.2020.11383","volume":"22","author":"B Ma","year":"2020","unstructured":"Ma B, Jia J, Wang X, Zhang R, Niu S, Ni L, et al. Differential roles of scavenger receptor class B type I: a protective molecule and a facilitator of atherosclerosis (review). Mol Med Rep. 2020;22(4):2599\u2013604. https:\/\/doi.org\/10.3892\/mmr.2020.11383.","journal-title":"Mol Med Rep"},{"key":"1606_CR37","doi-asserted-by":"crossref","unstructured":"Lin P, Yin F, Shen N, Liu N, Zhang B, Li Y, et al. Integrated bioinformatics analysis of the anti-atherosclerotic mechanisms of the polysaccharide CM1 from Cordyceps militaris. Int J Biol Macromol. 2021. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.10.175.","DOI":"10.1016\/j.ijbiomac.2021.10.175"},{"issue":"1","key":"1606_CR38","first-page":"17","volume":"45","author":"M Cucuianu","year":"2007","unstructured":"Cucuianu M, Coca M, H\u00e2ncu N. Reverse cholesterol transport and atherosclerosis. A mini review. Rom. J Intern Med. 2007;45(1):17\u201327.","journal-title":"J Intern Med"},{"key":"1606_CR39","doi-asserted-by":"crossref","unstructured":"Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M. Inhibitory effects of water extracts from fruiting bodies of cultured Cordyceps sinensis on raised serum lipid peroxide levels and aortic cholesterol deposition in atherosclerotic mice. Phytother Res. 2000;14(8):650\u20132. https:\/\/doi.org\/10.1002\/1099-1573(200012)14:8<650::AID-PTR675>3.0.CO;2-0.","DOI":"10.1002\/1099-1573(200012)14:8<650::AID-PTR675>3.0.CO;2-0"},{"key":"1606_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2015.04.004","volume":"132","author":"E Catry","year":"2015","unstructured":"Catry E, Pachikian BD, Salazar N, Neyrinck AM, Cani PD, Delzenne NM. Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sci. 2015;132:77\u201384. https:\/\/doi.org\/10.1016\/j.lfs.2015.04.004.","journal-title":"Life Sci"},{"issue":"7","key":"1606_CR41","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1194\/jlr.M027599","volume":"53","author":"LJ Engelking","year":"2012","unstructured":"Engelking LJ, McFarlane MR, Li CK, Liang G. Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes. J Lipid Res. 2012;53(7):1359\u201368. https:\/\/doi.org\/10.1194\/jlr.M027599.","journal-title":"J Lipid Res"},{"issue":"1","key":"1606_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12967-015-0452-x","volume":"13","author":"RX Xu","year":"2015","unstructured":"Xu RX, Liu J, Li XL, Li S, Zhang Y, Jia YJ, et al. Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms. J Transl Med. 2015;13(1):87. https:\/\/doi.org\/10.1186\/s12967-015-0452-x.","journal-title":"J Transl Med"},{"issue":"12","key":"1606_CR43","doi-asserted-by":"publisher","first-page":"158808","DOI":"10.1016\/j.bbalip.2020.158808","volume":"1865","author":"T Nakano","year":"2020","unstructured":"Nakano T, Inoue I, Takenaka Y, Ito R, Kotani N, Sato S, et al. Ezetimibe impairs transcellular lipid trafficking and induces large lipid droplet formation in intestinal absorptive epithelial cells. Biochim. Biophys. Acta Mol Cell Biol Lipids. 2020;1865(12):158808.","journal-title":"Biochim. Biophys. Acta Mol Cell Biol Lipids"},{"issue":"3","key":"1606_CR44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1194\/jlr.M600439-JLR200","volume":"48","author":"DE Telford","year":"2007","unstructured":"Telford DE, Sutherland BG, Edwards JY, Andrews JD, Barrett PH, Huff MW. The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. J Lipid Res. 2007;48(3):699\u2013708. https:\/\/doi.org\/10.1194\/jlr.M600439-JLR200.","journal-title":"J Lipid Res"},{"issue":"9","key":"1606_CR45","doi-asserted-by":"publisher","first-page":"G1043","DOI":"10.1152\/ajpgi.00250.2011","volume":"302","author":"M Naples","year":"2012","unstructured":"Naples M, Baker C, Lino M, Iqbal J, Hussain MM, Adeli K. Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2012;302(9):G1043\u201352. https:\/\/doi.org\/10.1152\/ajpgi.00250.2011.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"1606_CR46","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.3892\/mmr.2014.2623","volume":"10","author":"X Wang","year":"2014","unstructured":"Wang X, Ren Q, Wu T, Guo Y, Liang Y, Liu S. Ezetimibe prevents the development of non-alcoholic fatty liver disease induced by high-fat diet in C57BL\/6J mice. Mol Med Rep. 2014;10(6):2917\u201323. https:\/\/doi.org\/10.3892\/mmr.2014.2623.","journal-title":"Mol Med Rep"},{"issue":"24","key":"1606_CR47","doi-asserted-by":"publisher","first-page":"17924","DOI":"10.1016\/S0021-9258(17)46793-7","volume":"268","author":"M Shimada","year":"1993","unstructured":"Shimada M, Shimano H, Gotoda T, Yamamoto K, Kawamura M, Inaba T, et al. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J Biol Chem. 1993;268(24):17924\u20139. https:\/\/doi.org\/10.1016\/S0021-9258(17)46793-7.","journal-title":"J Biol Chem"},{"issue":"7","key":"1606_CR48","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s00125-004-1429-0","volume":"47","author":"S Kitajima","year":"2004","unstructured":"Kitajima S, Morimoto M, Liu E, Koike T, Higaki Y, Taura Y, et al. Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits. Diabetologia. 2004;47(7):1202\u20139. https:\/\/doi.org\/10.1007\/s00125-004-1429-0.","journal-title":"Diabetologia"},{"issue":"6","key":"1606_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","volume":"23","author":"LI Poulsen","year":"2012","unstructured":"Poulsen LI, Siersb\u00e6k M, Mandrup S. PPARs: fatty acid sensors controlling metabolism. Semin Cell Dev Biol. 2012;23(6):631\u20139. https:\/\/doi.org\/10.1016\/j.semcdb.2012.01.003.","journal-title":"Semin Cell Dev Biol"},{"key":"1606_CR50","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.foodres.2017.11.023","volume":"105","author":"NA Amirullah","year":"2018","unstructured":"Amirullah NA, Zainal Abidin N, Abdullah N. The potential applications of mushrooms against some facets of atherosclerosis: a review. Food Res Int. 2018;105:517\u201336. https:\/\/doi.org\/10.1016\/j.foodres.2017.11.023.","journal-title":"Food Res Int"},{"issue":"3","key":"1606_CR51","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1159\/000493297","volume":"49","author":"D Zhong","year":"2018","unstructured":"Zhong D, Xie Z, Huang B, Zhu S, Wang G, Zhou H, et al. Ganoderma lucidum polysaccharide peptide alleviates hepatoteatosis via modulating bile acid metabolism dependent on FXR-SHP\/FGF. Cell Physiol Biochem. 2018;49(3):1163\u201379. https:\/\/doi.org\/10.1159\/000493297.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"1606_CR52","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3390\/ijms18091930","volume":"18","author":"X Wang","year":"2017","unstructured":"Wang X, Shi L, Joyce S, Wang Y, Feng Y. MDG-1, a potential regulator of PPAR\u03b1 and PPAR\u03b3, ameliorates dyslipidemia in mice. Int J Mol Sci. 2017;18(9):1930. https:\/\/doi.org\/10.3390\/ijms18091930.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"1606_CR53","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1021\/acs.jafc.9b01321","volume":"67","author":"Z Yang","year":"2019","unstructured":"Yang Z, Liu G, Wang Y, Yin J, Wang J, Xia B, et al. Fucoidan A2 from the brown seaweed Ascophyllum nodosum lowers lipid by improving reverse cholesterol transport in C57BL\/6J mice fed a high-fat diet. J Agric Food Chem. 2019;67(20):5782\u201391. https:\/\/doi.org\/10.1021\/acs.jafc.9b01321.","journal-title":"J Agric Food Chem"},{"issue":"4","key":"1606_CR54","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.plipres.2012.06.001","volume":"51","author":"Q Liu","year":"2012","unstructured":"Liu Q, Siloto RM, Lehner R, Stone SJ, Weselake RJ. Acyl-CoA: diacylglycerol acyltransferase: molecular biology, biochemistry and biotechnology. Prog Lipid Res. 2012;51(4):350\u201377. https:\/\/doi.org\/10.1016\/j.plipres.2012.06.001.","journal-title":"Prog Lipid Res"},{"issue":"5","key":"1606_CR55","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s13238-020-00785-9","volume":"12","author":"L Jin","year":"2021","unstructured":"Jin L, Shi X, Yang J, Zhao Y, Xue L, Xu L, et al. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell. 2021;12(5):346\u201359. https:\/\/doi.org\/10.1007\/s13238-020-00785-9.","journal-title":"Protein Cell"},{"issue":"1","key":"1606_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/nu13010038","volume":"13","author":"SL Romero-C\u00f3rdoba","year":"2020","unstructured":"Romero-C\u00f3rdoba SL, Salido-Guadarrama I, Meneses ME, Cosentino G, Iorio MV, Tagliabue E, et al. Mexican Ganoderma Lucidum extracts decrease lipogenesis modulating transcriptional metabolic networks and gut microbiota in C57BL\/6 mice fed with a high-cholesterol diet. Nutrients. 2020;13(1):38. https:\/\/doi.org\/10.3390\/nu13010038.","journal-title":"Nutrients"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01606-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T03:02:33Z","timestamp":1639364553000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01606-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01606-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal study was approved by the laboratory animal ethics committee of Weifang Medical University (2020SDL106\u20133).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors agree to publish this article in the journal of Lipids in Health and Disease.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}